The emergency use authorization for COVID‐19 convalescent plasma reduced mortality

The emergency use authorization for COVID‐19 convalescent plasma reduced mortality

Bibliographic Details
Main Authors:	Nigel Paneth, Arturo Casadevall, Michael Joyner
Format:	Article
Language:	English
Published:	Wiley 2023-08-01
Series:	Health Science Reports
Online Access:	https://doi.org/10.1002/hsr2.1463

Similar Items

WHO Is Recommending against the Use of COVID-19 Convalescent Plasma in Immunocompromised Patients?
by: Massimo Franchini, et al.
Published: (2023-01-01)

Commentary on “Outcomes of Convalescent Plasma with Defined High versus Lower Neutralizing Antibody Titers against SARS-CoV-2 among Hospitalized Patients: CoronaVirus Inactivating Plasma (CoVIP) Study”
by: Michael J. Joyner, et al.
Published: (2022-12-01)

COVID-19 Serology Data Provide Guidance for Future Deployments of Convalescent Plasma
by: David Sullivan, et al.
Published: (2023-06-01)

Convalescent plasma for COVID-19 in oncohematological patients: a call for revision of the European Conference on Infections in Leukemia-9 (ECIL-9) guidelines
by: Daniele Focosi, et al.
Published: (2023-02-01)

The Role of Disease Severity and Demographics in the Clinical Course of COVID-19 Patients Treated With Convalescent Plasma
by: Tengfei Ma, et al.
Published: (2022-01-01)

On the Need to Determine the Contribution of Anti-Nucleocapsid Antibodies as Potential Contributors to COVID-19 Convalescent Plasma Efficacy
by: Daniele Focosi, et al.
Published: (2022-10-01)

Avoided and Avoidable Deaths with the Use of COVID-19 Convalescent Plasma in Italy during the First Two Years of Pandemic
by: Massimo Franchini, et al.
Published: (2024-09-01)

Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients
by: Massimo Franchini, et al.
Published: (2024-06-01)

The Emerging Role of Convalescent Plasma in the Treatment of COVID-19
by: Theodora Psaltopoulou, et al.
Published: (2020-06-01)

COVID-19 convalescent plasma: interim recommendations from the AABB
by: Cohn, CS, et al.
Published: (2021)

Convalescent Plasma Reduces Mortality and Decreases Hospitalization Stay in Patients with Moderate COVID-19 Pneumonia
by: Maamoun Basheer, et al.
Published: (2021-11-01)

Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis
by: Massimo Franchini, et al.
Published: (2024-02-01)

Convalescent plasma therapy in COVID-19
by: Ayse Uysal, et al.
Published: (2022-06-01)

Reduced Mortality among COVID-19 ICU Patients after Treatment with HemoClear Convalescent Plasma in Suriname
by: R. Bihariesingh-Sanchit, et al.
Published: (2023-04-01)

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients
by: Laura Thümmler, et al.
Published: (2022-12-01)

Convalescent (Immune) Plasma Therapy and COVID-19
by: Viroj Wiwanitkit
Published: (2020-11-01)

Convalescent plasma therapy in the management of COVID-19 patients and its effect on morbidity and mortality
by: Madhav Prabhu, et al.
Published: (2023-01-01)

Unusual Cardiac Presentation of COVID-19 and Use of Convalescent Plasma
by: William R. Hartman, et al.
Published: (2020-01-01)

Use of convalescent plasma to treat COVID-19: case studies
by: Stéphani Caroline Beneti, et al.
Published: (2023-07-01)

SEIR Mathematical Model of Convalescent Plasma Transfusion to Reduce COVID-19 Disease Transmission
by: Hennie Husniah, et al.
Published: (2021-11-01)

Convalescent plasma and all-cause mortality of COVID-19 patients: systematic review and meta-analysis
by: Nora Mihalek, et al.
Published: (2023-08-01)

Factors associated with mortality among hospitalized patients with COVID-19 disease treated with convalescent plasma
by: Armando M. Perichon, et al.
Published: (2023-12-01)

Effect of Convalescent Plasma Therapy on Mortality and Viral Load in Severely Ill Patients with COVID-19
by: Jan Moravec, et al.
Published: (2023-09-01)

Convalescent plasma for Covid-19 - making sense of the inconsistencies
by: Estcourt, L, et al.
Published: (2022)

Efficacy of convalescent plasma for treatment of COVID-19 in Uganda
by: Trishul Siddharthan, et al.
Published: (2021-01-01)

The Three Pillars of COVID-19 Convalescent Plasma Therapy
by: Massimo Franchini, et al.
Published: (2021-04-01)

Is Convalescent Plasma Therapy Effective for Patients with Covid-19?
by: Sadegh Zarei, et al.
Published: (2023-01-01)

Convalescent plasma for COVID-19 in the intensive care unit
by: Kazım Rollas, et al.
Published: (2021-12-01)

P1568: EARLY, BUT NOT LATE USE OF REMDESVIR AND CONVALESCENT PLASMA REDUCES MORTALITY OF COVID 19 IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES – A STUDY OF KROHEM
by: I. Aurer, et al.
Published: (2022-06-01)

International forum on the collection and use of COVID‐19 convalescent plasma: responses
by: Al‐Riyami, AZ, et al.
Published: (2021)

The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
by: Livius Tirnea, et al.
Published: (2021-03-01)

Efficacy of COVID-19 Convalescent Plasma Based on Antibody Concentration
by: Wesley V Cain, et al.
Published: (2022-01-01)

Effectiveness and Safety of Convalescent (Immune) Plasma Therapy in COVID-19
by: Öner Özdemir
Published: (2020-11-01)

Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19
by: Juan G. Ripoll, et al.
Published: (2024-05-01)

Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study
by: Ahmet Omma, et al.
Published: (2021-12-01)

Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious Diseases
by: Marijn Thijssen, et al.
Published: (2020-11-01)

How should we use convalescent plasma therapies for the management of COVID-19?
by: Wood, EM, et al.
Published: (2020)

Reduced monocyte proportions and responsiveness in convalescent COVID-19 patients
by: Eugene V. Ravkov, et al.
Published: (2024-01-01)

Biochemical rationale for transfusion of high titre COVID-19 convalescent plasma
by: Verbrugghe, C, et al.
Published: (2024)

Evaluation of the Effectiveness of Convalescent Plasma Therapy in Severe and Critical COVID-19
by: Özhan Özcan, et al.
Published: (2024-12-01)